Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

Recruiting in Palo Alto (17 mi)

+98 other locations

Overseen byTara O Henderson

Age: < 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Children's Oncology Group

No Placebo Group

Trial Summary

What is the purpose of this trial?

This research trial studies late effects after treatment in patients with previously diagnosed high-risk neuroblastoma. Studying late effects after treatment may help to decide which treatments for high-risk neuroblastoma are better tolerated with less side effects over time.

Research Team

Tara O Henderson

Principal Investigator

Children's Oncology Group

Eligibility Criteria

Inclusion Criteria

Patients must have been enrolled on COG neuroblastoma biology study ANBL00B1

Patient must have been diagnosed with high-risk neuroblastoma per ANBL00B1 definition

Patient must have been diagnosed on or after January 1, 2000

See 3 more

Treatment Details

Interventions

Cytology Specimen Collection Procedure (Procedure)
Laboratory Biomarker Analysis (Procedure)
Quality-of-Life Assessment (Other)

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Observational (specimen collection)Experimental Treatment3 Interventions

Patients undergo collection of blood and urine samples on day 1. Patients also undergo clinical assessments, laboratory, radiographic, and other ancillary studies on day 1.